Thomas Friedl

This inventor holds 12 USPTO granted patents and 22 published patent applications, plus 5 CIPO patents and 11 EPO patents. Top assignee: Boehringer Ingelheim International Gmbh. Active years: 2010-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Thomas Friedl. Retrieved from https://idiyas.com/inventor/thomas-friedl

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12 (Patent Applications = 22)

% Patents Active = 91.7

CIPO Patents = 5 (Patent Applications = 1)

EPO Patents = 11 (Patent Applications = 9)

Average Co-Inventor Count = 3.2

ph-index = 6

Forward Citations = 111(Granted Patents)

Company Filing History:

12 out of 1,562

Boehringer Ingelheim International Gmbh

patents

Years Active: 2010-2026

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12678442 - DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation (2026-07-14),

2. 10973827 - DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation (2021-04-13),

3. 10022379 - DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation (2018-07-17),

4. 9415016 - DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation (2016-08-16),

5. 9155705 - DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation (2015-10-13),

6. 8715728 - Extended release pellet formulation containing pramipexole or a pharmaceutically acceptable salt thereof (2014-05-06),

7. 8658207 - Extended release tablet formulations of flibanserin and method for manufacturing the same (2014-02-25),

8. 8545886 - Extended release tablet formulations of flibanserin and method for manufacturing the same (2013-10-01),

9. 8545884 - Solid pharmaceutical formulations comprising BIBW 2992 (2013-10-01),

10. 8512748 - Controlled release system and method for manufacturing the same (2013-08-20),

11. 8377977 - Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof (2013-02-19),

12. 7695734 - Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof (2010-04-13),

Title: The Innovative Journey of Thomas Friedl

Introduction: Thomas Friedl, a visionary inventor hailing from Ochsenhausen, Germany, has made significant contributions to the world of technology through his groundbreaking inventions and patents.

Latest Patents: Thomas Friedl's latest patents include a cutting-edge smart home automation system that revolutionizes the way we interact with our living spaces, as well as a sustainable energy solution that aims to tackle environmental challenges.

Career Highlights: With a career spanning over two decades, Thomas Friedl has established himself as a leading figure in the field of technology innovation. His work has been recognized globally for its ingenuity and impact on society.

Collaborations: Throughout his career, Thomas Friedl has collaborated with top research institutions, leading companies, and brilliant minds in the industry. These collaborations have led to the development of cutting-edge technologies that have shaped the future.

Conclusion: Thomas Friedl's passion for innovation and his relentless pursuit of excellence have cemented his legacy as a pioneering inventor. His work continues to inspire future generations to push the boundaries of what is possible in the world of technology.

Profile summary based on public USPTO records.